Real-world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non-interventional study in China

Cancer Commun (Lond). 2023 Jun;43(6):716-719. doi: 10.1002/cac2.12418. Epub 2023 Apr 11.
No abstract available

Publication types

  • Multicenter Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • China
  • Female
  • Humans
  • Indazoles / adverse effects
  • Ovarian Neoplasms*
  • Piperidines / adverse effects

Substances

  • niraparib
  • Indazoles
  • Piperidines